| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.32 | 1e-12 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-12 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.4 | 9e-12 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.3 | 7e-11 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-11 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |